Evidence map›Paper›PMID 31544742›Full record

ArticleLancet (London, England)2019

Analysis of the RIMDAMAL trial - Authors' reply.

Brian D Foy, Sangeeta Rao, Sunil Parikh, Hannah C Slater, Roch K Dabiré

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Ivermectin treatment in humans for reducing malaria transmission.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Review
  3. Article
  4. Broadening the range of use cases for ivermectin - a review of the evidence.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2022
    Review
  5. Article
  6. A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.The American journal of tropical medicine and hygiene · 2020
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Brian D FoyArthropod-borne and Infectious Diseases Laboratory, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523-1692, USA. Electronic address: brian.foy@colostate.edu.
Sangeeta RaoDepartment of Clinical Sciences, Colorado State University, Fort Collins, CO, USA.
Sunil ParikhDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Hannah C SlaterPATH, Seattle, WA, USA.
Roch K DabiréInstitute of Research in Health Sciences, Western Regional Direction, National Center for Scientific and Technological Research, Bobo-Dioulasso, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MalariaMass Drug AdministrationHumansIvermectinIvermectin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.